4
Changes in Ownership
Arcadia Biosciences, Inc. Filed Acc 0001209191-18-021805
VP Product Development sold 1,750 shares at $32.74 ($57,295)
- VP Product Development acquired 1,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lu Zhongjin VP Product Development | 2018-03-23 | Option exercise | +1,750 | $21.60 | $37,800 | 2,308 | D: show line 1 in the form |
| Lu Zhongjin VP Product Development | 2018-03-23 | Sale | −1,750 | $32.74 | $57,295 | 558 | D: show line 2 in the form |
| Open-market sales · 1,750 sh · avg $32.74 · $57,295 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lu Zhongjin VP Product Development | 2018-03-23 | Option exercise · Employee Stock Option (right to buy) | −1,750 | 10,438 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…